well maybe but they say its a tax thing. I guess if they want to include the revaluation as profit they should account for the potential tax on it too. Maybe thats it. Not sure.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
